PROGRAMME 10:00 - Prof. Dr. Andrew J. deMello, Institute for Chemical and Bioengineering,Department of Chemistry and Applied Biosciences, ETH Zürich, CH 8093 Zurich,Switzerland 10:30 - Prof. […]
Join this online Info Day and discover the wide range of support services that the European Medicines Agency (EMA) provides to researchers and SMEs in the pharmaceutical and med-tech sectors.
From 14 to 15 February 2023, the CLIB International Conference will take place in Düsseldorf, Germany, organised by CLIB - Cluster industrial biotechnology. Under the title […]
Rare Disease Day takes place on February 28th across the globe to raise awareness among policymakers and the public about rare diseases and their impact on patient's lives and their families...
EuropaBio’s first Biomanufacturing Policy Summit will set the vision for Europe’s global innovation, competitiveness and sustainability through the lens of biomanufacturing and set a baseline for […]
Germany's largest biotech event, the German Biotechnology Days 2023 (Deutsche Biotechnologietage, DBT), will take place on March 28th and 29th in Wiesbaden. The event is the national […]
CEBioForum is a brand that has been creating a business environment related to biotechnology for over 20 years, organizing the most important event of this type […]
The development of therapies (OMPs) for rare diseases comes with distinct challenges, including patient recruitment, setting meaningful clinical endpoints, manufacturing and supply and finding the regulatory and market pathway to ensure patients can access therapy.
The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2022, the conference […]
On 15th March, EuropaBio hosted its first Biomanufacturing Policy Summit in Brussels, with the aim of setting the vision for Europe's global innovation, competitiveness, and sustainability on biomanufacturing, while raising awareness among policy-makers.
From the ongoing revision of the EU pharmaceutical legislation package and addressing critical supply issues to the impact of the recent Medical Device Regulation transition period extension, the challenges in EU healthcare and pharmaceutical policy are ever-evolving.
The European Society of Applied Biocatalysis (ESAB) and the European Technology Platform for Sustainable Chemistry (SUSCHEM) will held a Webinar on Sustainable Chemistry, chaired by Pablo Domínguez de María (Sustainable Momentum SL, ESAB Working Group Sustainable Chemistry, SusChem Management Team) and Andrés R Alcántara (Complutense Univ of Madrid, ESAB Working Group Sustainable Chemistry, SusChem Board).
